Gad Propper sues Nestle for NIS 39m
Propper is demanding that Nestle pay him the same price for his Osem shares received by the public shareholders who sold their shares to Nestle four years later.
UBS cuts Teva's price target again
UBS gives two scenarios for Teva's share: an upside, in which the target price reaches $17, and a downside in which the target price drops to $1.
Israeli bitcoin holders take on banks
A freedom of information petition has been filed demanding that the banks reveal their policies on accounts for proceeds of cryptocurrency trading.